WSC 2025 - Visit us!

In just a few weeks, the 17th World Stroke Congress will take place in Barcelona. EVER Pharma is proud to be part of this important event and will present significant new study data.

Join our EVER Symposium on the 23rd October from 12:00 - 13:00!

Breakthroughs in AIS Therapy: Recent trial results in evidence-based cerebroprotection
Chair: Jennifer Manzano (Philippines)

• Circulating Tight Junction Proteins in Acute Ischemic Stroke Patients after Reperfusion Therapy combined with Cerebrolysin
  Sławomir Michalak (Poland)
• CREGS – Results of a large High-Quality Comparative Effectiveness Research Study
  Daniel Šaňák (Czech Republic)

We are pleased to announce that the new study data from CREGS will be presented in the High-Impact Registries Session by Prof. Michael Brainin.

Join the session for NEW insights!

Date: Thursday, 23rd October
Time: 17:15 – 18:45
Location: Room 115

Furthermore, we look forward to welcoming you at booth #13!

See you soon in Barcelona!